Production (Stage)
Repligen Corporation
RGEN
$118.15
-$2.30-1.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 169.17M | 167.55M | 154.87M | 158.84M | 153.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 169.17M | 167.55M | 154.87M | 158.84M | 153.18M |
| Cost of Revenue | 77.80M | 87.23M | 75.90M | 76.80M | 75.83M |
| Gross Profit | 91.37M | 80.31M | 78.97M | 82.04M | 77.35M |
| SG&A Expenses | 69.81M | 37.92M | 73.94M | 65.31M | 61.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 159.72M | 136.83M | 159.55M | 152.40M | 148.01M |
| Operating Income | 9.45M | 30.71M | -4.68M | 6.44M | 5.17M |
| Income Before Tax | 7.94M | -38.61M | -1.15M | 9.03M | 3.70M |
| Income Tax Expenses | 2.11M | -4.74M | -495.00K | 3.31M | 399.00K |
| Earnings from Continuing Operations | 5.83M | -33.87M | -654.00K | 5.71M | 3.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.83M | -33.87M | -654.00K | 5.71M | 3.30M |
| EBIT | 9.45M | 30.71M | -4.68M | 6.44M | 5.17M |
| EBITDA | 28.16M | 49.08M | 12.72M | 23.42M | 22.06M |
| EPS Basic | 0.10 | -0.60 | -0.01 | 0.10 | 0.06 |
| Normalized Basic EPS | 0.12 | 0.32 | 0.02 | 0.11 | 0.06 |
| EPS Diluted | 0.10 | -0.61 | -0.01 | 0.10 | 0.06 |
| Normalized Diluted EPS | 0.12 | 0.32 | 0.02 | 0.11 | 0.06 |
| Average Basic Shares Outstanding | 56.12M | 56.06M | 56.01M | 55.88M | 55.79M |
| Average Diluted Shares Outstanding | 56.56M | 56.06M | 56.01M | 56.43M | 56.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |